» Articles » PMID: 32892005

Dysregulated Lipid and Fatty Acid Metabolism Link Perfluoroalkyl Substances Exposure and Impaired Glucose Metabolism in Young Adults

Abstract

Background: Per- and polyfluoroalkyl substances (PFASs) exposure is ubiquitous among the US population and has been linked to adverse health outcomes including cardiometabolic diseases, immune dysregulation and endocrine disruption. However, the metabolic mechanism underlying the adverse health effect of PFASs exposure is unknown.

Objective: The aim of this project is to investigate the association between PFASs exposure and altered metabolic pathways linked to increased cardiometabolic risk in young adults.

Methods: A total of 102 young adults with 82% overweight or obese participants were enrolled from Southern California between 2014 and 2017. Cardiometabolic outcomes were assessed including oral glucose tolerance test (OGTT) measures, body fat and lipid profiles. High-resolution metabolomics was used to quantify plasma exposure levels of three PFAS congeners and intensity profiles of the untargeted metabolome. Fasting concentrations of 45 targeted metabolites involved in fatty acid and lipid metabolism were used to verify untargeted metabolomics findings. Bayesian Kernel Machine Regression (BKMR) was used to examine the associations between PFAS exposure mixture and cardiometabolic outcomes adjusting for covariates. Mummichog pathway enrichment analysis was used to explore PFAS-associated metabolic pathways. Moreover, the effect of PFAS exposure on the metabolic network, including metabolomic profiles and cardiometabolic outcomes, was investigated.

Results: Higher exposure to perfluorooctanoic acid (PFOA) was associated with higher 30-minute glucose levels and glucose area under the curve (AUC) during the OGTT (p < 0.001). PFAS exposure was also associated with altered lipid pathways, which contributed to the metabolic network connecting PFOA and higher glucose levels following the OGTT. Targeted metabolomics analysis indicated that higher PFOA exposure was associated with higher levels of glycerol (p = 0.006), which itself was associated with higher 30-minute glucose (p = 0.006).

Conclusions: Increased lipolysis and fatty acid oxidation could contribute to the biological mechanisms linking PFAS exposure and impaired glucose metabolism among young adults. Findings of this study warrants future experimental studies and epidemiological studies with larger sample size to replicate.

Citing Articles

Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident cancer burden attributable to PFAS in drinking water in the United States.

Li S, Oliva P, Zhang L, Goodrich J, McConnell R, Conti D J Expo Sci Environ Epidemiol. 2025; .

PMID: 39789195 DOI: 10.1038/s41370-024-00742-2.


Cord plasma metabolomic signatures of prenatal per- and polyfluoroalkyl substance (PFAS) exposures in the Boston Birth Cohort.

Li Z, Zhang M, Hong X, Wang G, Choi G, Nadeau K Environ Int. 2024; 194():109144.

PMID: 39615256 PMC: 11721280. DOI: 10.1016/j.envint.2024.109144.


Per-and polyfluoroalkyl substances and disrupted sleep: mediating roles of proteins.

Li S, Goodrich J, Chen J, Costello E, Beglarian E, Liao J Environ Adv. 2024; 17.

PMID: 39512894 PMC: 11542765. DOI: 10.1016/j.envadv.2024.100585.


TLR4 as a Potential Target of Me-PFOSA-AcOH Leading to Cardiovascular Diseases: Evidence from NHANES 2013-2018 and Molecular Docking.

Mao Z, Chen Y, Li H, Lu Q, Zhou K Toxics. 2024; 12(10).

PMID: 39453113 PMC: 11511422. DOI: 10.3390/toxics12100693.


The potential mediating role of the gut microbiome and metabolites in the association between PFAS and kidney function in young adults: A proof-of-concept study.

Hampson H, Li S, Walker D, Wang H, Jia Q, Rock S Sci Total Environ. 2024; 954():176519.

PMID: 39424468 PMC: 11731310. DOI: 10.1016/j.scitotenv.2024.176519.


References
1.
Alderete T, Jin R, Walker D, Valvi D, Chen Z, Jones D . Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis. Environ Int. 2019; 126:445-453. PMC: 6555482. DOI: 10.1016/j.envint.2019.02.047. View

2.
Liu K, Nellis M, Uppal K, Ma C, Tran V, Liang Y . Reference Standardization for Quantification and Harmonization of Large-Scale Metabolomics. Anal Chem. 2020; 92(13):8836-8844. PMC: 7887762. DOI: 10.1021/acs.analchem.0c00338. View

3.
Jin R, McConnell R, Catherine C, Xu S, Walker D, Stratakis N . Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach. Environ Int. 2019; 134:105220. PMC: 6944061. DOI: 10.1016/j.envint.2019.105220. View

4.
Patsouris D, Mandard S, Voshol P, Escher P, Tan N, Havekes L . PPARalpha governs glycerol metabolism. J Clin Invest. 2004; 114(1):94-103. PMC: 437964. DOI: 10.1172/JCI20468. View

5.
Hines E, White S, Stanko J, Gibbs-Flournoy E, Lau C, Fenton S . Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol Cell Endocrinol. 2009; 304(1-2):97-105. DOI: 10.1016/j.mce.2009.02.021. View